RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million doses per year of the world’s first registered vaccine against COVID-19, Sputnik V. The parties intend to commence technology transfer immediately. The […]
